Amanote Research
Register
Sign In
Figure 2: Prognostic Nomogram to Predict Patient’s ESRD Rate in 3 Years in Patients With Diabetic Nephropathy.
doi 10.7717/peerj.8499/fig-2
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Figure 3: Nomogram to Predict 3- And 5-Year Overall Survivals in Patients With Pelvic Ewing Sarcoma.
The Search for Molecular Prognostic Markers of Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus
International Journal of Biomedicine
Association of Diabetic Nephropathy With Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
International Journal of Advances in Medicine
Does Microalbuminuria Predict Diabetic Nephropathy?
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Complement Activation in Patients With Diabetic Nephropathy
Kidney International Reports
Nephrology
A Nomogram to Predict Lymph Node Metastasis in Patients With Early Gastric Cancer
Oncotarget
Oncology
Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients
Journal of Diabetes Research
Endocrinology
Metabolism
Diabetes
Status and Prognostic Nomogram of Patients With Burkitt Lymphoma
Oncology Letters
Cancer Research
Oncology
Figure 2: The Nine-lncRNA Prognostic Signature to Predict the Overall Survival of Colorectal Cancer Patients.
